WO2004035787A3 - Cellule transplantable - Google Patents

Cellule transplantable Download PDF

Info

Publication number
WO2004035787A3
WO2004035787A3 PCT/CH2003/000665 CH0300665W WO2004035787A3 WO 2004035787 A3 WO2004035787 A3 WO 2004035787A3 CH 0300665 W CH0300665 W CH 0300665W WO 2004035787 A3 WO2004035787 A3 WO 2004035787A3
Authority
WO
WIPO (PCT)
Prior art keywords
immune modulator
relates
transplantable cell
diseases
immune
Prior art date
Application number
PCT/CH2003/000665
Other languages
German (de)
English (en)
Other versions
WO2004035787A2 (fr
Inventor
Mark Burcin
Sybille Esser
Manfred Ruediger
Original Assignee
Hoffmann La Roche
Mark Burcin
Sybille Esser
Manfred Ruediger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Mark Burcin, Sybille Esser, Manfred Ruediger filed Critical Hoffmann La Roche
Priority to EP03747785A priority Critical patent/EP1556487A2/fr
Priority to CA002502312A priority patent/CA2502312A1/fr
Priority to MXPA05003912A priority patent/MXPA05003912A/es
Priority to JP2004543888A priority patent/JP2006502716A/ja
Priority to BR0315286-3A priority patent/BR0315286A/pt
Priority to AU2003266903A priority patent/AU2003266903A1/en
Publication of WO2004035787A2 publication Critical patent/WO2004035787A2/fr
Publication of WO2004035787A3 publication Critical patent/WO2004035787A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/02—Cells from transgenic animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)

Abstract

L'invention concerne une cellule humaine ou animale non totipotente, contenant au moins un acide nucléique codant au moins un immunomodulateur sous contrôle d'une molécule de commutation génétique pouvant être régulée par addition d'une substance active. L'invention concerne également la fabrication et l'utilisation de ladite cellule pour la transplantation, l'inhibition d'une réaction de rejet de transplantation, et la prophylaxie et/ou la thérapie de maladies auto-immunes et/ou de maladies faisant suite à une transplantation.
PCT/CH2003/000665 2002-10-14 2003-10-13 Cellule transplantable WO2004035787A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP03747785A EP1556487A2 (fr) 2002-10-14 2003-10-13 Cellule transplantable
CA002502312A CA2502312A1 (fr) 2002-10-14 2003-10-13 Cellule transplantable
MXPA05003912A MXPA05003912A (es) 2002-10-14 2003-10-13 Celula transplantable con modulador inmune.
JP2004543888A JP2006502716A (ja) 2002-10-14 2003-10-13 移植可能な細胞
BR0315286-3A BR0315286A (pt) 2002-10-14 2003-10-13 Célula transplantável
AU2003266903A AU2003266903A1 (en) 2002-10-14 2003-10-13 Transplantable cell

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02022868.0 2002-10-14
EP02022868 2002-10-14

Publications (2)

Publication Number Publication Date
WO2004035787A2 WO2004035787A2 (fr) 2004-04-29
WO2004035787A3 true WO2004035787A3 (fr) 2004-08-26

Family

ID=32103881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2003/000665 WO2004035787A2 (fr) 2002-10-14 2003-10-13 Cellule transplantable

Country Status (11)

Country Link
EP (1) EP1556487A2 (fr)
JP (1) JP2006502716A (fr)
KR (1) KR20050071579A (fr)
CN (1) CN1705744A (fr)
AU (1) AU2003266903A1 (fr)
BR (1) BR0315286A (fr)
CA (1) CA2502312A1 (fr)
MX (1) MXPA05003912A (fr)
PL (1) PL376397A1 (fr)
RU (1) RU2005114511A (fr)
WO (1) WO2004035787A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042189A2 (fr) 2008-10-08 2010-04-15 Intrexon Corporation Cellules modifiées exprimant des immuno-modulateurs multiples et leurs utilisations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733727A (en) * 1993-11-16 1998-03-31 Indiana University Foundation Myocardial grafts and cellular compositions
US5912411A (en) * 1993-06-14 1999-06-15 University Of Heidelberg Mice transgenic for a tetracycline-inducible transcriptional activator
WO2000012741A2 (fr) * 1998-08-28 2000-03-09 Transgene S.A. Systeme d'expression inductible
WO2001040494A1 (fr) * 1999-12-01 2001-06-07 Centre For Translational Research In Cancer Systeme inductible par medicament inductible et utilisation associee
WO2001071006A2 (fr) * 2000-03-24 2001-09-27 Franz Wolfgang M Procede d'isolation de cellules somatiques differenciees in vitro
WO2001087330A2 (fr) * 2000-05-12 2001-11-22 Beth Israel Deaconess Medical Center, Inc. Compositions et procedes pour obtenir une suppression immune

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912411A (en) * 1993-06-14 1999-06-15 University Of Heidelberg Mice transgenic for a tetracycline-inducible transcriptional activator
US5733727A (en) * 1993-11-16 1998-03-31 Indiana University Foundation Myocardial grafts and cellular compositions
WO2000012741A2 (fr) * 1998-08-28 2000-03-09 Transgene S.A. Systeme d'expression inductible
WO2001040494A1 (fr) * 1999-12-01 2001-06-07 Centre For Translational Research In Cancer Systeme inductible par medicament inductible et utilisation associee
WO2001071006A2 (fr) * 2000-03-24 2001-09-27 Franz Wolfgang M Procede d'isolation de cellules somatiques differenciees in vitro
WO2001087330A2 (fr) * 2000-05-12 2001-11-22 Beth Israel Deaconess Medical Center, Inc. Compositions et procedes pour obtenir une suppression immune

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FERRARI-LACRAZ S ET AL: "An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 167, no. 6, 15 September 2001 (2001-09-15), pages 3478 - 3485, XP002185137, ISSN: 0022-1767 *
KOH GOU YOUNG ET AL: "Targeted expression of transforming growth factor-beta-1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis", JOURNAL OF CLINICAL INVESTIGATION, vol. 95, no. 1, 1995, pages 114 - 121, XP008031081, ISSN: 0021-9738 *
See also references of EP1556487A2 *
STROM T B ET AL: "Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine.", TRANSPLANTATION PROCEEDINGS. UNITED STATES 2001 NOV-DEC, vol. 33, no. 7-8, November 2001 (2001-11-01), pages 3044 - 3049, XP002282652, ISSN: 0041-1345 *

Also Published As

Publication number Publication date
KR20050071579A (ko) 2005-07-07
WO2004035787A2 (fr) 2004-04-29
MXPA05003912A (es) 2005-09-30
AU2003266903A1 (en) 2004-05-04
BR0315286A (pt) 2005-08-30
RU2005114511A (ru) 2005-11-20
JP2006502716A (ja) 2006-01-26
CN1705744A (zh) 2005-12-07
CA2502312A1 (fr) 2004-04-29
PL376397A1 (en) 2005-12-27
EP1556487A2 (fr) 2005-07-27

Similar Documents

Publication Publication Date Title
AU2989300A (en) Controlling protein levels in eucaryotic organisms
WO2004002417A3 (fr) Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
WO2003084477A3 (fr) Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations
WO2005097175A3 (fr) Corps mimetiques glp-1 humains, compositions, procedes et utilisations
EP2284185A3 (fr) Inactivation de protéine de Bacillus licheniformis
WO2005081687A3 (fr) Mimeticorps de noyau-charniere humain, compositions, procedes et applications correspondantes
WO2006044204A3 (fr) Progeniteurs neuronaux obtenus par culture de cellules souches embryonnaires humaines sans cellules nourricieres
WO2005037257A3 (fr) Nouveaux inhibiteurs d'alanyl-aminopeptidases destines a exercer une influence fonctionnelle sur diverses cellules et a constituer un traitement immunologique de maladies inflammatoires, neuronales et autres
WO2002030470A8 (fr) Procedes et compositions permettant la diffusion d'acide nucleique
WO2005016867A3 (fr) Composes chimiques
WO2006017355A3 (fr) Variants d'aprotinine ameliores
WO2006056304A3 (fr) Regulation de l'expression et de l'activite de l'indoleamine 2,3 dioxygenase
WO2005034876A3 (fr) Utilisation de lignees cellulaires pour produire des proteines therapeutiques actives
WO2004035787A3 (fr) Cellule transplantable
UY29544A1 (es) Tratamiento de enfermedades usando un sistema mejorado de expresión regulada
WO2004000207A3 (fr) Antibiotique bactéricide à bactériophages et utilisations de ce dernier
WO2005037219A3 (fr) Compositions de desinfection des mamelles
AU2002319236A1 (en) Method for the production of protamine
WO2006031993A3 (fr) Augmentation de la production d'hemoglobine recombinee par co-expression avec la proteine de stabilisation de l'hemoglobine alpha
ATE452970T1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
WO2007081302A3 (fr) Miméticorps de la glp-1 humaine, compositions, procédés et utilisations
WO2004000313A3 (fr) Traitement de la sclerose laterale amyotrophique avec des composes modulateurs de l’activite de pgc-1
WO2001085096A3 (fr) Regulation des mastocytes
WO2005021776A3 (fr) Methodes d'utilisation d'une rnase h de mammifere et de compositions a base de celle-ci
WO2005033266A3 (fr) Regulation de l'expression d'acheron

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003266903

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/003912

Country of ref document: MX

Ref document number: 2502312

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 376397

Country of ref document: PL

Ref document number: 2004543888

Country of ref document: JP

Ref document number: 1020057006477

Country of ref document: KR

Ref document number: 20038A14139

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2003747785

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005114511

Country of ref document: RU

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1020057006477

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003747785

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003747785

Country of ref document: EP